Detection, diagnosis and treatment of certain cancers, infectious disease and other abnormalities using targeted electromagnetic resonance. Our patient process is rapid, non-invasive with very few side effects. The advanced software and hardware platform facilitates development of new diagnostics and therapies within months, not years, at relatively low cost. Our patented process and devices are in their 6th generation, and clinical trials have shown effectiveness against HIV and preclinical success with tuberculosis and certain aggressive cancers. We are based out of Des Moines, Iowa, in the United States of America.
